Personalized mRNA vaccine shows promise for biliary cancer patients
Disease control
Recruiting now
This study tests a personalized mRNA vaccine called iNeo-Vac-R01 for people with biliary cancer who have had surgery to remove their tumor. The vaccine is designed to train the immune system to attack cancer cells based on each patient's unique tumor markers. The main goal is to …
Phase: PHASE1, PHASE2 • Sponsor: Yifan Wang • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC